Tubular Adenomas And The Adenoma-Carcinoma Sequence
Published on: August 7, 2025
Tubular Adenomas And The Adenoma-Carcinoma Sequence
Article author photo

Nurah Ekhlaque

Masters in Biotechnology, <a href="https://www.ggu.ac.in/" rel="nofollow">Guru Ghasidas University</a>

Article reviewer photo

Hafsa Raja

Masters in Biotechnology

Introduction

Colorectal cancer (CRC) ranks among the most common and deadly cancers worldwide, contributing significantly to cancer-related mortality. A major contributor to CRC development is the adenoma-to-carcinoma sequence, a well-established process in which benign polyps in the colon and rectum undergo genetic mutations, transforming into malignant tumours. Tubular adenomas, one of the most common types of precancerous polyps, play a significant role in this progression.

Understanding the characteristics, diagnosis approaches, and risk factors of tubular adenomas is crucial for preventing CRC. This article explores the nature of tubular adenomas, their histopathological features, and how they fit into the adenoma-carcinoma sequence, along with screening and prevention strategies to reduce the risk of colorectal cancer.

What are tubular adenomas?

Definition and characteristics

A tubular adenoma is a type of colorectal polyp that arises from the glandular epithelium cells lining the colon and rectum. It is classified as a precancerous lesion, indicating that it has the potential to develop into colorectal carcinoma if left untreated.

Key characteristics of tubular adenomas include:

  • Size: Typically, these adenomas measure less than 1 cm in diameter but may grow larger. The risk of malignancy increases with size.
  • Structure: They exhibit a tubular architecture, consisting of elongated, tightly packed glandular structures.
  • Appearance: They can be either pedunculated (attached by a stalk) or sessile (flat without a stalk).
  • Dysplasia: Tubular adenomas exhibit dysplastic changes that can be classified as low-grade or high-grade, affecting their likelihood of malignant transformation.

Histopathology of tubular adenomas

Histological examination provides valuable insights into the cellular abnormalities and growth patterns within tubular adenomas:

  • Glandular Architecture: These adenomas consist of tightly arranged, elongated glands, forming a tubular pattern.
  • Epithelial Dysplasia: This refers to abnormal cell growth, including:
    • Nuclear enlargement
    • Hyperchromasia (dark-staining nuclei due to increased DNA content)
    • Increased mitotic activity (more frequent cell division)
  • Low-Grade vs. High-Grade Dysplasia:
    • Low-grade dysplasia: Mild structural abnormalities with minimal nuclear changes
    • High-grade dysplasia: More pronounced nuclear atypia, loss of cell polarity, and an increased number of mitotic figures, significantly raising the risk of malignant transformation

The adenoma-carcinoma sequence: how cancer develops

Stepwise genetic alterations

The transition from a benign adenoma to invasive colorectal carcinoma occurs through a well-characterised sequence of genetic mutations. Each step in this process represents a key molecular alteration that drives   tumorigenesis  progression 

APC gene mutation – Initiation of polyp formation

  • The APC (Adenomatous Polyposis Coli) gene is a tumour suppressor gene that regulates cell adhesion and proliferation
  • Mutations in APC disrupt β-catenin signalling, leading to uncontrolled cell growth and the formation of small adenomatous polyps
  • This early mutation is seen in both sporadic colorectal cancer and hereditary conditions like Familial Adenomatous Polyposis (FAP)

KRAS mutation – Driving unregulated cellular proliferation

  • KRAS is an oncogene involved in cell signalling pathways
  • A KRAS mutation results in constant activation of cell division signals, allowing adenomas to grow larger and progress
  • KRAS mutations are detected in about 40–50% of colorectal adenomas

TP53 mutation – Malignant transformation and loss of apoptosis

  • TP53 is a tumour suppressor gene responsible for regulating DNA repair and apoptosis (programmed cell death)
  • Loss of TP53 function allows genetically damaged cells to survive, enabling adenomas to develop into malignant colorectal carcinoma

SMAD4 and other mutations – Invasive cancer development

  • SMAD4 mutations disrupt the TGF-β signalling pathway, leading to unregulated tumour growth.
  • Additional genetic changes promote tumour invasion, metastasis, and angiogenesis (new blood vessel formation).

Factors that influence malignant transformation in tubular adenomas

Tubular adenomas are the most common type of precancerous polyps found in the colon and rectum. While not all progress to colorectal cancer (CRC), certain factors increase their risk of malignant transformation. These factors include polyp size, histological type, dysplasia severity, and the number of adenomas present. Identifying and addressing these risks through early detection, screening, and timely removal is crucial in preventing CRC development.

Size of the polyp

  • The size of a polyp is a major determinant of its potential for malignant  progression. Larger polyps accumulate more genetic mutations and are more likely to exhibit high-grade dysplasia or develop into invasive carcinoma. Polyps <1 cm – Low risk of malignancy
  • Polyps >1 cm – Increased cancer risk compared to smaller polyps
  • Polyps >2 cm30–50% chance of containing high-grade dysplasia or invasive carcinoma

Why Size Matters:

  • Larger polyps have more cell divisions, increasing the likelihood of genetic mutations
  • Sessile polyps (flat lesions) are harder to remove completely, increasing cancer risk
  • Pedunculated polyps (stalked lesions) are easier to remove and less likely to leave residual tissue

Clinical Action:

  • Polyps >1 cm should be removed immediately to minimise cancer risk
  • Regular colonoscopy screenings are necessary for patients with larger adenomas

Histological type of the adenoma

The microscopic structure of an adenoma influences its cancer risk. Different histological subtypes exhibit varying degrees of malignancy potential.

  • Tubular Adenomas (Low Risk) – Most common (75–85%), small, pedunculated, and lower cancer risk
  • Tubulovillous Adenomas (Moderate Risk) – Mix of tubular and villous structures, higher risk as the villous component increases
  • Villous Adenomas (High Risk) – Composed of finger-like projections, high cellular turnover, and aggressive behavior, making them most likely to progress to CRC

Why Histology Matters:

  • Tubular adenomas have the lowest cancer risk, while villous adenomas have the highest
  • Tubulovillous adenomas fall in between, with risk increasing as the villous component grows
  • Larger villous or tubulovillous adenomas (>1 cm) should be removed immediately due to their malignancy potential

Degree of dysplasia

Dysplasia refers to abnormal cellular changes that indicate a polyp’s progression toward malignancy.

  • Low-Grade Dysplasia – Minimal structural abnormalities, low risk of immediate progression
  • High-Grade DysplasiaSevere nuclear atypia, loss of cell polarity, increased mitotic activity, and a strong predictor of malignant transformation

Why Dysplasia Matters:

  • Low-grade dysplasia is less concerning but should be monitored
  • High-grade dysplasia signals imminent malignant transformation and requires urgent removal
  • Adenomas with high-grade dysplasia need frequent follow-up screenings

Number of adenomas

Having multiple adenomas increases CRC risk, often indicating a genetic predisposition.

  • Patients with ≥3 adenomas have a significantly higher risk of developing CRC
  • Multiple adenomas suggest an underlying hereditary condition such as FAP or Lynch Syndrome

Hereditary Conditions with High Polyp Burden:

  • Familial Adenomatous Polyposis (FAP)Hundreds to thousands of adenomas, inevitable CRC progression by early adulthood unless treated.
  • Lynch Syndrome (HNPCC) – Fewer adenomas than FAP but faster adenoma-to-carcinoma progression, leading to early-onset CRC.

Why the Number of Adenomas Matters:

  • 1–2 small adenomas pose a lower risk, but multiple adenomas significantly increase CRC risk
  • Genetic syndromes like FAP or Lynch Syndrome require early and frequent screenings
  • Patients with multiple adenomas should have closer surveillance and polyp removal

Diagnosis and screening for tubular adenomas

Screening techniques

Early detection plays a vital role in preventing colorectal cancer. Available screening methods include:

  • Colonoscopy: The gold standard for adenoma detection and removal
  • Faecal Occult Blood Test (FOBT) & Faecal Immunochemical Test (FIT): Detect hidden blood in stool, which may indicate polyp presence
  • CT Colonography (Virtual Colonoscopy): A non-invasive imaging technique that can identify large polyps

Colonoscopy and polypectomy

During a colonoscopy, adenomas can be removed using:

  • Cold biopsy forceps: For small polyps
  • Snare polypectomy: For larger, pedunculated polyps
  • Endoscopic Mucosal Resection (EMR): For larger, sessile adenomas

Prevention and risk reduction strategies

Preventing the progression of tubular adenomas to colorectal cancer (CRC) involves a combination of lifestyle modifications, dietary interventions, and chemoprevention strategies. Adopting proactive measures can significantly reduce the likelihood of adenoma formation and malignant transformation.

Diet and lifestyle modifications play a crucial role in lowering the risk of colorectal cancer (CRC). A high-fibre diet rich in vegetables, fruits, and whole grains helps promote gut health and reduce polyp formation. Regular physical activity has been shown to lower inflammation, improve digestion, and enhance immune function, all of which contribute to a healthier colon. Conversely, excessive consumption of red and processed meats has been linked to an increased risk of colorectal cancer due to the formation of carcinogenic compounds during cooking and processing. Additionally, avoiding tobacco and excessive alcohol intake is essential, as both have been associated with an increased risk of adenoma development and CRC progression.

In addition to lifestyle modifications, chemopreventive strategies involving pharmacological agents have been explored as a potential strategy to reduce adenoma recurrence. Studies suggest that aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) may help lower the risk of adenomas by inhibiting inflammation and cell proliferation in the colon. Additionally, calcium and vitamin D supplementation have been investigated for their protective roles against polyp formation, though their efficacy is still being studied.

Overall, a combination of healthy dietary practices, regular physical activities, smoking cessation, alcohol moderation, and targeted chemoprevention can play a significant role in preventing the formation and progression of colorectal adenomas, ultimately reducing the incidence of colorectal cancer. Among all preventive measures, regular colonoscopic screening remains the most effective strategy, ensuring early detection and timely removal of high-risk polyps.

Summary

Tubular adenomas are common precancerous lesions that can progress to colorectal cancer through the adenoma-to-carcinoma sequence. This transformation is driven by genetic mutations, including APC, KRAS, and TP53, leading to uncontrolled cellular proliferation and malignancy.

Early colonoscopic screening and polypectomy remain the most effective prevention methods. Lifestyle modifications, including a high-fibre diet, regular exercise, and reduced intake of processed foods, further contribute to lowering the risk of colorectal cancer.

FAQs

How often should I get screened for colorectal polyps?

  • Most guidelines recommend a colonoscopy every 10 years starting at age 45 for average-risk individuals
  • Those with a family history of CRC may need earlier and more frequent screenings

Can tubular adenomas disappear on their own?

  • No, tubular adenomas do not regress and must be removed to prevent progression to cancer.

Is surgery required for all adenomas?

  • No, most adenomas are removed endoscopically during a colonoscopy. Surgery is only needed for very large or invasive adenomas.

References

  1. Hong, Qin, et al. ‘Transcriptomic Analyses of the Adenoma-Carcinoma Sequence Identify Hallmarks Associated With the Onset of Colorectal Cancer’. Frontiers in Oncology, vol. 11, Aug. 2021, p. 704531. PubMed Central, https://doi.org/10.3389/fonc.2021.704531.
  2. Hall, Jason F. ‘Management of Malignant Adenomas’. Clinics in Colon and Rectal Surgery, vol. 28, no. 4, Dec. 2015, pp. 215–19. PubMed Central, https://doi.org/10.1055/s-0035-1564434.
  3. Witold, Kycler, et al. ‘Adenomas – Genetic Factors in Colorectal Cancer Prevention’. Reports of Practical Oncology & Radiotherapy, vol. 23, no. 2, Mar. 2018, pp. 75–83. ScienceDirect, https://doi.org/10.1016/j.rpor.2017.12.003.
Share

Nurah Ekhlaque

Masters in Biotechnology, Guru Ghasidas University

I'm a highly motivated and skilled biotechnology professional, known for my strong background in research and laboratory work. My proficiency extends to cryosectioning, immunohistochemistry, confocal imaging, and various molecular biology techniques. I am detail-oriented and dedicated to consistently producing high-quality results.

My educational journey led me to a Master's degree in Biotechnology from Guru Ghasidas Vishwavidyalaya, India. This academic foundation, combined with my practical experience, fuels my commitment to advancing scientific research and improving human health.

My practical experience includes roles as a Research Assistant at Saarland University in Germany and as an Internship Research Trainee at the All India Institute of Medical Sciences. In these positions, I mastered the use of cryosectioning, immunohistochemistry, and various laboratory techniques, consistently delivering high-quality data for scientific research.

arrow-right